Suloctidil

This classification denotes a vasodilator agent with the molecular formula C20H35NOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XV1N1XY17K, chemically known as (r*,s*)-4-(isopropylthio)-alpha-(1-(octylamino)ethyl)benzyl alcohol but generally known as suloctidil, which bears US NIH Compound Identifier 5354. European Medicines Agency schedules Suloctidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10752MIG. World Health Organization schedules suloctidil in its Anatomical Therapeutic Chemical (ATC) Classification. SULOCTIDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule suloctidil under HS 29309085 and SITC 51549. As of Q4 2014, SULOCTIDIL remains the US FDA Preferred Term for this commodity. SMILES: S(c1ccc(C(O)C(NCCCCCCCC)C)cc1)C(C)C.